DE69738312D1 - Hepatitis b monoklonale antikörper - Google Patents

Hepatitis b monoklonale antikörper

Info

Publication number
DE69738312D1
DE69738312D1 DE69738312T DE69738312T DE69738312D1 DE 69738312 D1 DE69738312 D1 DE 69738312D1 DE 69738312 T DE69738312 T DE 69738312T DE 69738312 T DE69738312 T DE 69738312T DE 69738312 D1 DE69738312 D1 DE 69738312D1
Authority
DE
Germany
Prior art keywords
hepatitis
monoclonal antibodies
monoclonal
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69738312T
Other languages
English (en)
Other versions
DE69738312T2 (de
Inventor
Richard Seton Tedder
Samreen Ijaz
Ruth Bridget Ferns
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Murex Diagnostics Corp
Original Assignee
Murex Diagnostics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Murex Diagnostics Corp filed Critical Murex Diagnostics Corp
Application granted granted Critical
Publication of DE69738312D1 publication Critical patent/DE69738312D1/de
Publication of DE69738312T2 publication Critical patent/DE69738312T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
DE69738312T 1996-04-25 1997-04-25 Hepatitis b monoklonale antikörper Expired - Lifetime DE69738312T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9608626 1996-04-25
GBGB9608626.9A GB9608626D0 (en) 1996-04-25 1996-04-25 Hepatitis b monoclonal antibodies
PCT/GB1997/001161 WO1997040164A1 (en) 1996-04-25 1997-04-25 Hepatitis b monoclonal antibodies

Publications (2)

Publication Number Publication Date
DE69738312D1 true DE69738312D1 (de) 2008-01-03
DE69738312T2 DE69738312T2 (de) 2008-10-02

Family

ID=10792667

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69738312T Expired - Lifetime DE69738312T2 (de) 1996-04-25 1997-04-25 Hepatitis b monoklonale antikörper

Country Status (10)

Country Link
US (1) US7393933B1 (de)
EP (1) EP0904378B1 (de)
JP (1) JP4118955B2 (de)
AU (1) AU2645297A (de)
CA (1) CA2252466C (de)
DE (1) DE69738312T2 (de)
ES (1) ES2297855T3 (de)
GB (1) GB9608626D0 (de)
WO (1) WO1997040164A1 (de)
ZA (1) ZA973664B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118626A0 (en) * 1996-06-11 1996-10-16 Xtl Biopharmaceuticals Limited Anti HBV antibody
WO1998029442A1 (en) * 1996-12-30 1998-07-09 Innogenetics N.V. ANNEXIN V-BINDING POLYPEPTIDES DERIVED FROM HBsAg AND THEIR USES
EP1111388A1 (de) * 1999-12-23 2001-06-27 Universiteit Gent Interaktion zwischen CD14 und HBV-Komponenten
JP4772199B2 (ja) * 2000-03-31 2011-09-14 オーソ−クリニカル・ダイアグノスティックス・インコーポレイテッド 新規なｂ型肝炎ウイルス
FR2815634B1 (fr) * 2000-10-20 2003-10-31 Biomerieux Sa Anticorps monoclonaux diriges contre des virus de l'hepatite b
DE10339927A1 (de) * 2003-08-29 2005-03-24 Rhein Biotech Gesellschaft für neue Biotechnologische Prozesse und Produkte mbH Zusammensetzung zur Prophylaxe/Therapie von HBV-Infektionen und HBV-vermittelten Erkrankungen
WO2006085918A2 (en) * 2004-06-07 2006-08-17 Novartis Vaccines And Diagnostics Inc. Rabbit monoclonal antibodies to hepatitis b surface antigens and methods of using the same
WO2006076640A1 (en) * 2005-01-14 2006-07-20 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Monoclonal antibodies that bind or neutralize hepatitis b virus
JP4948783B2 (ja) 2005-05-18 2012-06-06 シスメックス株式会社 抗ＨＢｓモノクローナル抗体
WO2008053901A1 (en) * 2006-10-30 2008-05-08 Advanced Life Science Institute, Inc. METHOD FOR ANALYSIS OF HEPATITIS B VIRUS s ANTIGEN
CN107921285B (zh) * 2015-03-25 2022-06-07 Igm生物科学股份有限公司 多价乙型肝炎病毒抗原结合分子及其应用
WO2017059878A1 (en) * 2015-10-07 2017-04-13 Humabs Biomed Sa Antibodies that potently neutralize hepatitis b virus and uses thereof
RU2765878C2 (ru) * 2017-04-07 2022-02-04 Сямэнь Юниверсити Антитела для лечения инфекции гепатитом в и связанных с ней заболеваний
KR102084912B1 (ko) * 2019-01-17 2020-03-05 주식회사 녹십자 B형 간염 바이러스 표면 항원의 입체 에피토프 및 이에 특이적으로 결합하는 항체
CN111659355B (zh) * 2020-06-23 2022-12-13 武汉瑞法医疗器械有限公司 烷基化修饰的乙肝病毒免疫吸附剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU681636B2 (en) * 1993-03-24 1997-09-04 Imperial College Of Science, Technology And Medicine Hepatitis B escape mutant specific binding molecules
GB9401987D0 (en) * 1994-02-02 1994-03-30 Imperial College Modified nucleic acid

Also Published As

Publication number Publication date
CA2252466C (en) 2010-04-06
JP2000509269A (ja) 2000-07-25
CA2252466A1 (en) 1997-10-30
DE69738312T2 (de) 2008-10-02
EP0904378B1 (de) 2007-11-21
JP4118955B2 (ja) 2008-07-16
ES2297855T3 (es) 2008-05-01
AU2645297A (en) 1997-11-12
EP0904378A1 (de) 1999-03-31
ZA973664B (en) 1998-08-20
US7393933B1 (en) 2008-07-01
WO1997040164A1 (en) 1997-10-30
GB9608626D0 (en) 1996-07-03

Similar Documents

Publication Publication Date Title
DK1516629T3 (da) Humaniseret anti-CD-11a antibodies
NO955167D0 (no) Monoklonalt anti-
DE69920897D1 (de) Monoklonale antikörper mit verringerter immunisierungsfähigkeit
CY2005008I2 (el) Αντισωματα αντι - vegf
IL128406A0 (en) Monoclonal antibodies
NO985464D0 (no) Konsentrert antistoffpreparat
DK145493D0 (da) Antistof
DK0837927T3 (da) Anti-CD80-antistoffer
DE69935516D1 (de) Antikörper mit verbesserter produzierbarkeit
DE69738312D1 (de) Hepatitis b monoklonale antikörper
DE69828154D1 (de) Anti-alphavbeta3 humanizierte monoklonale antikörper
NO981454L (no) Anti-FAS-antistoffer
BR9509902A (pt) Fragmentos de anticorpos monoclonais apresentando atividade imunosupressante
NO20011006L (no) Höy-affinitets antistoffer
GB9718911D0 (en) Monoclonal antibodies
DE69427850D1 (de) Monoklonaler antikörper gegen mucoglykoprotein
NO985281D0 (no) Monoklonalt antihumant MP52-antistoff
GB9722943D0 (en) Hepatitis B virus monoclonal antibodies
GB9722944D0 (en) Hepatitis B virus monoclonal antibodies
DE69324928T2 (de) Monoklonaler antikörper
BR1100555B1 (pt) anticorpos monoclonais humanizados.
GB9615027D0 (en) Monoclonal antibodies
SE9701168D0 (sv) Methods for determining canmcer antigens
BR1100504A (pt) anticorpos anti-ige.
IL127249A0 (en) Human monoclonal antibodies to the hepatitis b surface antigen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition